Showing results (121-130 of 201) with videos related to

Sort By:
Pageof 21
Bone Marrow Transplantation|November 18, 2008
Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AMLR M Saliba, K V Komanduri, S Giralt, et al.
Ecological Indicators|July 2, 2025
Unveiling two millennia of ecosystem changes in the Azores through elementome trajectory analysisJ de la Casa, S Nogué, M De Cáceres, et al.
Bone Marrow Transplantation|April 21, 2001
Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survivalK van Besien, A Rodriguez, S Tomany, et al.
Bone Marrow Transplantation|August 8, 2006
Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignanciesL Lekakis, S Giralt, D Couriel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2001
Adenovirus infections in adult recipients of blood and marrow transplantsA M La Rosa, R E Champlin, N Mirza, et al.
Bone Marrow Transplantation|July 31, 2001
Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipientsS Konoplev, R E Champlin, S Giralt, et al.
Leukemia|April 26, 2017
Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomesP Hari, M-V Mateos, R Abonour, et al.
Blood|May 23, 2001
Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantationJ Storek, M A Dawson, B Storer, et al.
Leukemia|December 20, 2017
Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyondC S Chim, S K Kumar, R Z Orlowski, et al.
Bone Marrow Transplantation|February 10, 2015
Allo-SCT for myelofibrosis: reversing the chronic phase in the JAK inhibitor era?R Tamari, T I Mughal, D Rondelli, et al.
Pageof 21